Literature DB >> 22924926

Toxoplasma gondii seroprevalence in Mali.

Dinkorma T Ouologuem1, Abdoulaye A Djimdé, Nouhoum Diallo, Ogobara K Doumbo, David S Roos.   

Abstract

The protozoan parasite Toxoplasma gondii is globally distributed, with considerable local variation in prevalence based on behavioral and environmental factors. To assess prevalence and estimate risk in Mali, we conducted a survey of 760 serum samples previously collected for malaria studies. A modified agglutination test detected antibodies in ∼27% of the adult population, with no significant differences between men and women, or between urban and rural study sites. In the village of Kolle, seroprevalence rose from 0% in infants (<1 yr, but after weaning of maternal immunoglobulin G) to 0.8% (1-5 yr), 2.7% (6-10), 11.3% (11-15), and 26.8% (>15); differences between the <10-, 11-15-, and >15-yr age groups were highly significant (P ≤ 0.01). We also observed an increase in anti- T. gondii antibody titers with age. Modeling the observed age distribution suggests a seroconversion rate of ∼1%/yr, indicating that congenital toxoplasmosis may be an under-appreciated public health concern in Mali.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22924926      PMCID: PMC6810635          DOI: 10.1645/GE-3239.1

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  50 in total

1.  Seroprevalence of Toxoplasma gondii antibodies amongst pregnant women at the Lagos State University Teaching Hospital, Nigeria.

Authors:  A A Akinbami; A A Adewunmi; K A Rabiu; K O Wright; A O Dosunmu; M O Dada; T A Adeyemo
Journal:  Niger Postgrad Med J       Date:  2010-06

2.  National seroprevalence of Toxoplasma gondii in India.

Authors:  M Dhumne; C Sengupta; G Kadival; A Rathinaswamy; A Velumani
Journal:  J Parasitol       Date:  2007-12       Impact factor: 1.276

3.  Congenital toxoplasmosis. A prospective study of 378 pregnancies.

Authors:  G Desmonts; J Couvreur
Journal:  N Engl J Med       Date:  1974-05-16       Impact factor: 91.245

4.  [Prevalence of antitoxoplasma antibodies in patients with acquired immunodeficiency syndrome and blood donors in Bamako].

Authors:  I Maïga; P Kiemtoré; A Tounkara
Journal:  Bull Soc Pathol Exot       Date:  2001-08

5.  Differential agglutination test for diagnosis of recently acquired infection with Toxoplasma gondii.

Authors:  B R Dannemann; W C Vaughan; P Thulliez; J S Remington
Journal:  J Clin Microbiol       Date:  1990-09       Impact factor: 5.948

Review 6.  Toxoplasma gondii: from animals to humans.

Authors:  A M Tenter; A R Heckeroth; L M Weiss
Journal:  Int J Parasitol       Date:  2000-11       Impact factor: 3.981

7.  Contributions to the history of ocular toxoplasmosis in Southern Brazil.

Authors:  J Melamed
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-03       Impact factor: 2.743

8.  Fetal toxoplasmosis: outcome of pregnancy and infant follow-up after in utero treatment.

Authors:  P Hohlfeld; F Daffos; P Thulliez; C Aufrant; J Couvreur; J MacAleese; D Descombey; F Forestier
Journal:  J Pediatr       Date:  1989-11       Impact factor: 4.406

9.  Efficacy of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria: revisiting molecular markers in an area of emerging AQ and SP resistance in Mali.

Authors:  Mamadou Tekete; Abdoulaye A Djimde; Abdoul H Beavogui; Hamma Maiga; Issaka Sagara; Bakary Fofana; Dinkorma Ouologuem; Souleymane Dama; Aminatou Kone; Demba Dembele; Mamadou Wele; Alassane Dicko; Ogobara K Doumbo
Journal:  Malar J       Date:  2009-02-26       Impact factor: 2.979

10.  Seroepidemiology of human Toxoplasma gondii infection in China.

Authors:  Yue Xiao; Jigang Yin; Ning Jiang; Mei Xiang; Lili Hao; Huijun Lu; Hong Sang; Xianying Liu; Huiji Xu; Johan Ankarklev; Johan Lindh; Qijun Chen
Journal:  BMC Infect Dis       Date:  2010-01-07       Impact factor: 3.090

View more
  4 in total

1.  Sero-epidemiology and risk factors for Toxoplasma gondii among pregnant women in Arab and African countries.

Authors:  Mohamed Alkhatim Alsammani
Journal:  J Parasit Dis       Date:  2014-09-20

2.  Seroprevalence and risk factors of Toxoplasma gondii infection in humans in East Hararghe Zone, Ethiopia.

Authors:  B Tilahun; Y Hailu; G Tilahun; H Ashenafi; M Vitale; V Di Marco; E Z Gebremedhin
Journal:  Epidemiol Infect       Date:  2015-06-15       Impact factor: 4.434

Review 3.  Overview of the effect and epidemiology of parasitic central nervous system infections in African children.

Authors:  Macpherson Mallewa; Jo M Wilmshurst
Journal:  Semin Pediatr Neurol       Date:  2014-02-06       Impact factor: 1.636

4.  Seroprevalence of toxoplasmosis in pregnant women of the Marrakech-Safi region, Morocco.

Authors:  Laila Hoummadi; Salma Berrouch; Yassine Amraouza; Abdelaziz Adel; Mostafa Mriouch; Nabila Soraa; Younes El Jahiri; Laila Zoughari; Abdelkrim Benbouzid; El Mostafa Miss; Redouan Moutaj; Jamaleddine Hafid
Journal:  Afr Health Sci       Date:  2020-03       Impact factor: 0.927

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.